[Quantifying dialysis efficiency for middle molecules in haemodialysis and in convective and mixed techniques]
- PMID: 18264920
[Quantifying dialysis efficiency for middle molecules in haemodialysis and in convective and mixed techniques]
Abstract
In contrast to the negative results of the primary analysis, secondary analyses of the HEMO study do support the clinical importance of middle molecule removal. This is in agreement with the findings of large observational studies showing an improvement in mortality and morbidity in dialysis patients treated with high-flux hemodialysis or convective techniques as compared to low-flux hemodialysis. For practical assessment of middle molecule removal, we suggest using the Kt/V of beta2-microglobulin (Kt/Vbeta2-m) with a reference (adequate) value of >or=0.66, which was the average value for the high-flux arm in the HEMO study. For patients on low-flux hemodialysis, where Kt/Vbeta2-m cannot reliably be assessed, we suggest using the Kt/V of vitamin B12 (Kt/VB12), with a reference (adequate) value of >or=0.74, adapted from the findings of the Case Mix Adequacy Study (AJKD 1999). To simplify the routine assessment of these indices, two nomograms are introduced: the first allows to estimate Kt/Vbeta2-m from the post- to pre-dialysis beta2-microglobulin concentration ratio, the second allows to estimate the diffusion dialysis clearance of vitamin B12 from the in vitro dialyzer KoAB12 and actual plasma water flow rate. While waiting for specific trials addressing the issue of dialysis adequacy related to middle molecule removal, clinical experience with the middle molecule indices could provide further quantitative tools for dialysis prescription and favor an increase in dialysis time (or frequency) and/or the use of high-flux hemodialysis and convective techniques.
Similar articles
-
Increasing dialysate flow rate increases dialyzer urea clearance and dialysis efficiency: an in vivo study.Saudi J Kidney Dis Transpl. 2009 Nov;20(6):1023-9. Saudi J Kidney Dis Transpl. 2009. PMID: 19861865
-
Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.Blood Purif. 2007;25(5-6):432-40. doi: 10.1159/000110069. Epub 2007 Oct 23. Blood Purif. 2007. PMID: 17957097 Clinical Trial.
-
Can convective therapies improve dialysis outcomes?Curr Opin Nephrol Hypertens. 2009 Nov;18(6):476-80. doi: 10.1097/MNH.0b013e3283318e8b. Curr Opin Nephrol Hypertens. 2009. PMID: 19726986 Review.
-
[On-line haemodiafiltration with sorbent-regenerated ultrafiltrate as replacement fluid: Beta2-microglobulin removal versus filtration fraction].G Ital Nefrol. 2004 Nov-Dec;21 Suppl 30:S80-4. G Ital Nefrol. 2004. PMID: 15747312 Italian.
-
Advantages of new hemodialysis membranes and equipment.Nephron Clin Pract. 2010;114(3):c165-72. doi: 10.1159/000262298. Epub 2009 Nov 28. Nephron Clin Pract. 2010. PMID: 19955821 Review.
Cited by
-
Early intensive treatment to prevent kidney failure in post-traumatic rhabdomyolysis: Case report.SAGE Open Med Case Rep. 2019 Apr 3;7:2050313X19839529. doi: 10.1177/2050313X19839529. eCollection 2019. SAGE Open Med Case Rep. 2019. PMID: 30984397 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical